Department of Urology, Rennes University Hospital, Rennes, France.
Department of Urology, Angers University Hospital, Angers, France.
World J Urol. 2019 Dec;37(12):2727-2736. doi: 10.1007/s00345-019-02724-8. Epub 2019 Mar 20.
Modalities of surveillance to detect recurrence after nephrectomy for localized or locally advanced renal tumor are not standardized. The aim was to assess the impact of surveillance scheme on oncological outcomes.
Patients treated for localized or locally advanced renal tumor with total or partial nephrectomy between 2006 and 2010 in an academic institution were included retrospectively. According to the University of California Los Angeles Integrated Staging System (UISS) protocol, follow-up was considered adequate or not. Symptoms, location and number of lesions at recurrence diagnosis were collected. Recurrence-free, cancer-specific and overall survivals were estimated using the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazards regression models were calculated to identify prognostic factors.
A total of 267 patients were included. Median follow-up was 72 months. Recurrence rate was 23.2% (62/267 patients). Recurrences were local (16%), single metastatic (23%), oligo-metastatic (15%) or multi-metastatic (46%). 72.6% of the recurrences occurred within the 3 years after surgery. No recurrence was diagnosed by chest X-ray or abdominal ultrasound. One hundred and twenty-one patients had inadequate follow-up. They had similar recurrence-free survival, cancer-specific survival and overall survival as patients with adequate follow-up. In multivariable analysis, the presence of multi-metastatic lesions was an independent prognostic factor of worse cancer-specific mortality after recurrence diagnosis (HR = 10.15, 95% CI: 2.29-44.82, p = 0.002).
Role of chest X-ray and abdominal ultrasound for the detection of recurrences is limited. Rigorous follow-up according to the UISS protocol does not improve oncological outcomes. Follow-up schedules with less frequent imaging should be discussed.
检测局限性或局部进展性肾肿瘤肾切除术后复发的监测方法尚未标准化。本研究旨在评估监测方案对肿瘤学结局的影响。
回顾性纳入 2006 年至 2010 年在一所学术机构接受局限性或局部进展性肾肿瘤全肾或部分肾切除术治疗的患者。根据加利福尼亚大学洛杉矶分校综合分期系统(UISS)方案,随访被认为是充分或不充分的。收集复发时的症状、病变位置和数量。采用 Kaplan-Meier 法估计无复发生存率、癌症特异性生存率和总生存率,并采用对数秩检验进行比较。采用 Cox 比例风险回归模型确定预后因素。
共纳入 267 例患者。中位随访时间为 72 个月。复发率为 23.2%(267 例患者中有 62 例)。复发为局部(16%)、单转移(23%)、寡转移(15%)或多转移(46%)。72.6%的复发发生在术后 3 年内。胸部 X 线或腹部超声未发现复发。121 例患者的随访不充分。与随访充分的患者相比,他们的无复发生存率、癌症特异性生存率和总生存率相似。多变量分析显示,多转移病灶的存在是复发后癌症特异性死亡率的独立预后因素(HR=10.15,95%CI:2.29-44.82,p=0.002)。
胸部 X 线和腹部超声在检测复发方面的作用有限。根据 UISS 方案进行严格的随访并不能改善肿瘤学结局。应讨论更不频繁进行影像学检查的随访方案。